Ecallantide comment watch save
BreastfeedingGeriatricPediatric

  • TRADE NAME: Kalbitor (Dyax)
  • INDICATIONS: Acute attacks of hereditary angioedema (HAE) in patients 16 years of age and older
  • CLASS: Plasma kallikrein inhibitor
  • HALF-LIFE: ~2hours
  • CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
    None known

Please login to view the rest of this drug profile.

Page last updated 07/31/2023

Symbol key

Incidence

<1% 1‑5% 5‑10% 10‑15% 15‑20% 20‑30% >30%

Seriousness

Hospitalization possible
Life threatening
Fatal

Warnings in other populations

BreastfeedingBreast feeding

GeriatricGeriatric

PediatricPediatric

Back to top